INTRODUCTION AND OBJECTIVES:
The increase of obesity among patients with end-stage renal disease poses a major challenge for urologists and nephrologists. Many centers set an upper limit on body mass index (BMI) to place a patient on the active waiting list due worse outcomes regarding delayed graft function (DGF), acute rejection episodes and graft survival. However, obesity is also related to a higher risk of surgical complications. This study was undertaken to determine the increase risk of surgical complications in relation to BMI.
METHODS: This study was a retrospective review of 2,212 renal transplant recipients in a single-institution database from January 1999 to October 2017. Combined transplantations and children were excluded. Recipients were classified based on BMI at the time of transplantation: non-obese (BMI < 25 kg/m 2 ), overweight (25 BMI < 30), class I obese (30 BMI < 35), class II obese (35 BMI < 40) and class III obese (BMI ! 40). The analysis included vascular, ureteral, wound infection, parietal dehiscence (superficial, eventration and evisceration), incisional hernia, need for intervention and hospital stay.
RESULTS: In total, there were 231 events in 226 patients. Multivariable logistic regression indicated significantly increased risk for early and late wound complications. Risk increased 1.9-fold for each 5 points of BMI (p<0.001), reaching 17.5, 29.0, 45.0 and 60% with BMIs of 30, 35, 40 and 45, respectively. Wound infection and evisceration were the complications most associated with the increasing BMI (2.0-and 2.7-fold for each 5 points of BMI, respectively. p<0.001), figure 1. Less than 50% of wound infections and superficial dehiscence events require intervention, while the others events require intervention almost 100% of the time. Among the complications, there was no difference in patient hospitalization (26,2 AE 20,4; P[ 0.42). The was also no difference in incidence of vascular and ureteral complications with a overall incidence of 0,7 and 1,5%.
CONCLUSIONS: In this large series, we show that obesity greatly increases early and late wound complications and is associated with a higher necessity of reoperations. Based on this data we avoid kidney transplant surgery in patients with IMC > 40.
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Atakelet A Ferede*, Gordon Smyth, Ponnusamy Mohan, Richard Power, James Forde, Dilly M Little, Dublin, Ireland INTRODUCTION AND OBJECTIVES: Renal failure is common complication among recipients of prior nonrenal solid organ transplants, predominantly due to calcineurin inhibitor toxicity. As a result of extended life expectancy and better quality of life, these patients are increasingly being referred for consideration for kidney transplantation. In this study we examined our experience of recipients of kidney transplant post nonrenal solid organ transplantation and compare them to age-matched repeat kidney transplant recipients.
METHODS: This is a retrospective review of a prospectively maintained database from the National Kidney Transplant Service (NKTS) of Republic of Ireland. The study period was from August 1993 to August 2017 and included adult living and deceased donor kidney transplant recipients. Patients who received kidney transplant after other solid organ transplantation were reviewed and were compared to patients who received repeat kidney transplant in the same period.
RESULTS: There were a total of 433 patients in the study cohort (38 recipients of kidney transplant post other nonrenal solid organ transplant and 395 recipients of repeat kidney transplant). Baseline and transplant-specific characteristics of study population are outlined in Table 1 . Death-censored 1-,5-and 10-year graft survival for the two groups were 94.7%/93.7%, 87.3%/86.4%, 78.6%/74%, respectively (P[509) (Figure 1) . CONCLUSIONS: Our national experience demonstrates that patients receiving kidney transplant after nonrenal solid organ transplant can expect allograft survival similar to patients receiving repeat kidney transplant.
